TOKYO, Sept 20, 2019 - (JCN Newswire) - - Eisai Co., Ltd. and Meiji Seika Pharma Co., Ltd. has announced the manufacturing and marketing approval in Japan for the indication of improvement of ...
Safinamide belongs to a class of drugs called monoamine oxidase type B inhibitors and is used in conjunction with levodopa to manage OFF periods. Treatment with safinamide 50 mg may significantly ...
First new oral treatment for Parkinson's Disease approved in over a decade Parkinson's Disease affects a growing number of Canadians with over 100,000 currently afflicted Total Canadian market for ...
MONTREAL, QUEBEC, July 10, 2019 – Valeo Pharma Inc. (CSE:VPH) (“Valeo”), a Canadian specialty pharmaceutical company with a primary focus on Neurodegenerative Diseases and Oncology, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results